nach oben

Erschienen in:

22.03.2021 | COVID-19 | Case Report Zur Zeit gratis

Optic neuritis following SARS-CoV-2 infection

verfasst von: Mónica Saray Rodríguez-Rodríguez, Rosa María Romero-Castro, Claudia Alvarado-de la Barrera, María Gabriela González-Cannata, Ana Karen García-Morales, Santiago Ávila-Ríos

Erschienen in: Journal of NeuroVirology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

The most common neurologic symptoms in COVID-19 are headache, anosmia, and dysgeusia. Optic neuritis is an unusual manifestation of SARS-CoV-2 infection. We report a case of a patient who initially consulted for vision loss in the absence of respiratory symptoms. She was diagnosed with optic neuritis following SARS-CoV-2 infection. Delay in diagnosis of neuro-ophthalmic manifestations of COVID-19 may lead to irreversible optic atrophy. A mechanism in which viral antigens would induce an immune response against self-proteins, or direct SARS Cov-2 infection of the central nervous system, may be involved in optic nerve injury.

Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, Misu T, Nakazawa T, Fujihara K, Aoki M (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87:446–448. https://doi.org/10.1136/jnnp-2014-310206CrossRefPubMed

Benito-Pascual B, Gegúndez JA, Díaz-Valle D, Arriola-Villalobos P, Carreño E, Culebras E, Rodríguez-Avial I, Benítez-Del Castillo JM (2020) Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm 28:922–925. https://doi.org/10.1080/09273948.2020.1792512CrossRefPubMed

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544. https://doi.org/10.1038/s41564-020-0695-zCrossRef

Cyr DG, Vicidomini CM, Siu NY, Elmann SE (2020) Severe bilateral vision loss in 2 patients with coronavirus disease 2019. J Neuroophthalmol 40:403–405. https://doi.org/10.1097/WNO.0000000000001039CrossRefPubMed

Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P, Harpe J, Greer C, Mints G, Salama G, Tsiouris AJ, Leifer D (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95:221–223CrossRef

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen A, Defres A, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol 19:767–783. https://doi.org/10.1016/S1474-4422(20)30221-0CrossRefPubMedPubMedCentral

Gutierrez-Ortiz C, Mendez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, de Aragón-Gómez F, Benito-León J (2020) Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 95:e601–e605. https://doi.org/10.1212/WNL.0000000000009619CrossRefPubMed

Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López-Vázquez Á, Ferro-Osuna M (2020) Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol 1120672120947591. https://doi.org/10.1177/1120672120947591

Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163. https://doi.org/10.1212/NXI.0000000000000163CrossRefPubMedPubMedCentral

Lukiw WJ, Pogue A, Hill JM (2020) SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-020-00947-7CrossRefPubMedPubMedCentral

Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez CM, Díaz-Maroto I, Segura T (2020) Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 45:102377. https://doi.org/10.1016/j.msard.2020.102377CrossRefPubMedPubMedCentral

Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung V, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson A, Barnett MH, Reddel SW, Brilot F, Dale RC, Australasian and New Zealand MOG Study Group (2018) Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry 89:127–137. https://doi.org/10.1136/jnnp-2017-316880CrossRefPubMed

Shaw VC, Chander G, Puttanna A (2020) Neuromyelitis optica spectrum disorder secondary to COVID-19. Br J Hosp Med 81(9):1-3 https://doi.org/10.12968/hmed.2020.0401

Tsai LK, Hsieh ST, Chang YC (2005) Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan 14:113–119PubMed

Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR (2020) Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol 40:398–402. https://doi.org/10.1097/WNO.0000000000001049CrossRefPubMed

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 77:1018–1027. https://doi.org/10.1001/jamaneurol.2020.2065CrossRefPubMedPubMedCentral

Titel: Optic neuritis following SARS-CoV-2 infection
verfasst von: Mónica Saray Rodríguez-Rodríguez
Rosa María Romero-Castro
Claudia Alvarado-de la Barrera
María Gabriela González-Cannata
Ana Karen García-Morales
Santiago Ávila-Ríos
Publikationsdatum: 22.03.2021
Verlag: Springer International Publishing
Schlagwörter: COVID-19
Optikusneuritis
Neurologische Beteiligung bei Infektionserkrankungen
Erschienen in: Journal of NeuroVirology / Ausgabe 2/2021
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-021-00959-z

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Optic neuritis following SARS-CoV-2 infection

Abstract

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Expanding the etiologic spectrum of spastic ataxia syndrome: chronic infection with human T lymphotropic virus type 1

Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy

Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice

Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31

Varicella zoster virus infection in neurological patients in Bulgaria

A comprehensive data-driven analysis framework for detecting impairments in brain function networks with resting state fMRI in HIV-infected individuals on cART

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein